Description of Collaborative Activity: |
In 2008, the ODS, NCCAM and FDA/CFSAN initiated a systematic review through the AHRQ to evaluate the evidence for safety of probiotics. The collaboration has consisted of intellectual exchange of knowledge expertise and appropriate guidance during monthly teleconferences. |